Preview Mode Links will not work in preview mode

Johnson & Johnson Innovation is committed to advancing new healthcare solutions through collaboration. Our Podcast explores the latest trends in healthcare and the thinkers, organizations, and ideas behind them.

Aug 27, 2018

On this episode of the J&J Innovation Podcast, we sit down with Artie Suckow, chief scientific officer of DTx Pharma, who explains what an "oligonucleotide therapeutic" is, and how they can potentially prevent disease-causing proteins from expressing themselves. We also talk to Jeff Friedman, who details his journey from investor to chief operations officer of DTx.